Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Defining Psychology01:24

Defining Psychology

7.8K
Psychology is the scientific discipline dedicated to understanding both observable behavior and the internal mental processes underlying such behavior. It aims to comprehend human nature and apply this understanding to solve practical problems, enhance well-being, and improve societal outcomes. An example of psychology's application is the study of prosocial behavior, such as why and under what conditions individuals might help strangers in need. This process involves describing observed...
7.8K
Defining Social Psychology01:09

Defining Social Psychology

416
Social psychology investigates how the presence and actions of others influence individual behavior, cognition, and emotion. Examining the social environment's impact provides a scientific framework for understanding how individuals perceive others and are, in turn, influenced by them. This field seeks to uncover the underlying principles guiding social interactions, exploring phenomena such as conformity, obedience, and prosocial behavior.Core Themes in Social PsychologyOne central focus of...
416
Polymers: Defining Molecular Weight01:01

Polymers: Defining Molecular Weight

3.8K
Unlike small molecules with definite molecular weights, polymers are a mixture of individual polymer chains of varying lengths, each with a unique molecular weight.  So, the molecular weight of a polymer is expressed as an average value based on the average size of the polymer chains. The two most common forms of averages used for polymers are the number average molecular weight and weight average molecular weight.
The number average molecular weight (Mn) is the summation of the number...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.1K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

896
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
896
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

989
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
989

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integration of Primary Preventive Care of Cardiovascular Disease in a Retroviral Clinic in an adult retroviral clinic in Ibadan: A retrospective study.

Nigerian journal of clinical practice·2024
Same author

APOLIPOPROTEIN E GENE POLYMORPHISMS AND PLASMA LIPIDS IN PERSONS LIVING WITH HIV: A CROSS SECTIONAL STUDY.

Annals of Ibadan postgraduate medicine·2024
Same author

BURDEN OF CYTOPAENIAS AMONG HIV POSITIVE PREGNANT WOMEN AT THE UNIVERSITY COLLEGE HOSPITAL, IBADAN.

Annals of Ibadan postgraduate medicine·2019
Same author

HCV co-infection is associated with metabolic abnormalities among HAART naive HIV-infected persons.

Nigerian journal of clinical practice·2017
Same author

Discordant rapid HIV tests: lessons from a low-resource community.

HIV medicine·2017
Same author

Process and outcome measures of quality of care at the diabetes outpatient clinic, University College Hospital, Ibadan.

Nigerian journal of clinical practice·2017

Related Experiment Video

Updated: Jan 28, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.1K

Defining apolipoprotein B treatment targets.

G O Ayoade1, M A Kuti2

  • 1Department of Chemical Pathology, University College Hospital, Ibadan, Nigeria.

Nigerian Journal of Clinical Practice
|March 7, 2019
PubMed
Summary

Apolipoprotein B (apo B) is a better cardiovascular risk predictor than LDL-C. This study establishes apo B targets for Nigerians, showing gender and age influence, aiding dyslipidemia management.

Keywords:
Apolipoprotein Blow density lipoprotein cholesteroltreatment targets

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.5K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.2K

Related Experiment Videos

Last Updated: Jan 28, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.1K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.5K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.2K

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Public Health

Background:

  • Apolipoprotein B (apo B) is increasingly recognized as a superior marker for cardiovascular risk compared to low-density lipoprotein cholesterol (LDL-C).
  • Establishing population-specific apo B treatment targets is crucial for effective cardiovascular risk management.
  • Previous studies have advocated for apo B targets based on LDL-C equivalencies derived from population data.

Purpose of the Study:

  • To determine apo B values equivalent to established LDL-C medical decision targets in a healthy Nigerian population.
  • To investigate the influence of demographic factors, specifically gender and age, on apo B levels.
  • To provide data for guiding dyslipidemia therapy initiation in Nigeria.

Main Methods:

  • A cross-sectional study involving 252 healthy Nigerian adults (89 males, 163 females) aged 30-65 years.
  • Participants were selected from health workers at University College Hospital Ibadan.
  • Serum lipids and apo B were measured using enzymatic and immunoturbidimetry methods, respectively.

Main Results:

  • Mean apo B levels were 94 mg/dL in men and 98 mg/dL in women.
  • Apo B concentrations were significantly higher in females over 55 years old.
  • LDL-C levels of 100, 130, 160, and 190 mg/dL corresponded to apo B levels of 73, 95, 124, and 145 mg/dL, respectively.
  • Participants with LDL-C <130 mg/dL and apo B <95 mg/dL shared similar clinical and biochemical characteristics.

Conclusions:

  • This study defines specific apo B targets for the Nigerian population, useful for initiating dyslipidemia therapy.
  • It elucidates the relationship between apo B and LDL-cholesterol at the population level.
  • The findings highlight the impact of gender and age on apo B distribution, informing personalized risk assessment.